Tag Cloud Results
Results found matching tag Cancer
From the News
apceth Received the Second Round of Funding for Its Innovative Stem Cell-Based Cancer Therapeutic as ...
Novartis highlights key data in patients with hematologic diseases and breast cancer with more than ...
Keystone Mercy Health Plan, P4 Healthcare Help Community Oncologists Extend Quality Cancer Care to Underserved ...
ZYTIGA Approved in the European Union for Metastatic Castration-Resistant Prostate Cancer
QIAGEN to develop new companion diagnostic for compound in clinical trials for blood cancers
Roche’s Tarceva receives European approval for first-line use in a genetically distinct type of lung ...
Abbott Introduces New ALK Genetic Test for Specific Form of Non-Small-Cell Lung Cancer
Abbott Receives FDA Approval for ALK Gene Test for Lung Cancer Therapy Selection
Listerine cancer claim triggers court battle
FDA Grants Fast Track Designation to Bayer’s Investigational Compound Alpharadin for the Treatment ...
FDA Approves Zelboraf and Companion Diagnostic for BRAF Mutation-Positive Metastatic Melanoma, a Deadly ...
FDA approves Zelboraf (vemurafenib) and companion diagnostic for BRAF mutation-positive metastatic melanoma, ...
QIAGEN and Pfizer partner to develop companion diagnostic for novel compound in global clinical trials ...
Lung Cancer: A Decision Support Tool for Optimizing the Pipeline from Research To Market
Scientists find new ovarian cancer gene
QIAGEN completes second U.S. submission for companion diagnostic to guide treatment decisions in colorectal ...
GE's Latest Radiotherapy Simulation CT Systems Target Cancer
Zytiga (Abiraterone Acetate) Receives Health Canada Approval For Treatment Of Metastatic Prostate Cancer
ZYTIGA Receives Positive Regulatory Recommendation in the European Union for Treatment of Metastatic ...
Sigma Life Science Launches Genetically Modified Human Cell Lines for Breast Cancer Research
Roche’s Tarceva gains positive CHMP opinion for first-line use in genetically distinct type of lung ...
Roche acquires mtm laboratories AG, expanding offering in cervical cancer
Roche acquires mtm laboratories AG, expanding offering in cervical cancer testing
Pertuzumab Combined with Herceptin and Chemotherapy Significantly Extended the Time People with HER2-Positive ...
Analysis: Biotech buys seen in cancer, immunology, neurology
Pertuzumab combined with Herceptin and chemotherapy significantly extended the time people with HER2-positive ...
Lilly Donation to Patient Advocate Foundation Expands Services and Access for Patients With Most Common ...
New breast cancer model of mutant PI3K recapitulates features of human breast cancer
Novartis drug Afinitor® met primary endpoint of Phase III study in women with advanced breast cancer; ...
Cancer treatments: New information from fission yeast
Basilea initiates first-in-human study with its novel anti-cancer drug BAL101553
Genentech Provides Update from FDA Hearing on Avastin for Metastatic Breast Cancer
Roche provides update from FDA hearing on Avastin for metastatic breast cancer
Life Technologies Consortium to Create New Frontline Diagnostic Utilising DNA Sequencing for Cancer Patients ...
Abbott Receives FDA Approval for a New Six-Month Formulation of Lupron Depot® (leuprolide acetate for ...
Genentech, Curis Pass Clinical Trial With Skin Cancer Drug, Look Ahead to FDA
Pivotal study showed vismodegib helped shrink tumours or heal lesions in people with rare form of advanced ...
New Data in Breast and Ovarian Cancer Presented at ASCO Support Continued Development of Iniparib
ZALTRAP Significantly Improved Survival in Previously Treated Metastatic Colorectal Cancer Patients
Blood Clotting and Bowel Cancer Risk
Teva Announces Successful Results of Phase III Study of Its Long-Acting G-CSF Product in Breast Cancer ...
Phase 1b Trial of Retaspimycin HCl in Combination With Docetaxel Shows Encouraging Response Rates in ...
Alpharadin Significantly Improves Overall Survival in Phase III Trial in Patients with Prostate Cancer
Review: “DKFZ-ZMBH Alliance Forum on Aging & Cancer” in Heidelberg
Infinity Reports Results From Phase 1b Clinical Trial of IPI-926 in Pancreatic Cancer at ASCO Meeting
Roche announces data to show Avastin based regimen halved the risk of disease getting worse in women ...
New Study Showed Patients With Deadly Form of Lung Cancer Lived Longer Without Disease Worsening
Tarceva nearly doubled the time people with a genetically distinct type of lung cancer lived without ...
Roche enters collaboration with Bristol-Myers Squibb to study combination therapy with vemurafenib and ...
Teva Announces Data on Granulocyte Colony Stimulating Factor Compounds for the Prevention of Chemotherapy-Induced ...
From the News
apceth Received the Second Round of Funding for Its Innovative Stem Cell-Based Cancer Therapeutic as ...
Novartis highlights key data in patients with hematologic diseases and breast cancer with more than ...
Keystone Mercy Health Plan, P4 Healthcare Help Community Oncologists Extend Quality Cancer Care to Underserved ...
ZYTIGA Approved in the European Union for Metastatic Castration-Resistant Prostate Cancer
QIAGEN to develop new companion diagnostic for compound in clinical trials for blood cancers
Roche’s Tarceva receives European approval for first-line use in a genetically distinct type of lung ...
Abbott Introduces New ALK Genetic Test for Specific Form of Non-Small-Cell Lung Cancer
Abbott Receives FDA Approval for ALK Gene Test for Lung Cancer Therapy Selection
Listerine cancer claim triggers court battle
FDA Grants Fast Track Designation to Bayer’s Investigational Compound Alpharadin for the Treatment ...
FDA Approves Zelboraf and Companion Diagnostic for BRAF Mutation-Positive Metastatic Melanoma, a Deadly ...
FDA approves Zelboraf (vemurafenib) and companion diagnostic for BRAF mutation-positive metastatic melanoma, ...
QIAGEN and Pfizer partner to develop companion diagnostic for novel compound in global clinical trials ...
Lung Cancer: A Decision Support Tool for Optimizing the Pipeline from Research To Market
Scientists find new ovarian cancer gene
QIAGEN completes second U.S. submission for companion diagnostic to guide treatment decisions in colorectal ...
GE's Latest Radiotherapy Simulation CT Systems Target Cancer
Zytiga (Abiraterone Acetate) Receives Health Canada Approval For Treatment Of Metastatic Prostate Cancer
ZYTIGA Receives Positive Regulatory Recommendation in the European Union for Treatment of Metastatic ...
Sigma Life Science Launches Genetically Modified Human Cell Lines for Breast Cancer Research
Roche’s Tarceva gains positive CHMP opinion for first-line use in genetically distinct type of lung ...
Roche acquires mtm laboratories AG, expanding offering in cervical cancer
Roche acquires mtm laboratories AG, expanding offering in cervical cancer testing
Pertuzumab Combined with Herceptin and Chemotherapy Significantly Extended the Time People with HER2-Positive ...
Analysis: Biotech buys seen in cancer, immunology, neurology
Pertuzumab combined with Herceptin and chemotherapy significantly extended the time people with HER2-positive ...
Lilly Donation to Patient Advocate Foundation Expands Services and Access for Patients With Most Common ...
New breast cancer model of mutant PI3K recapitulates features of human breast cancer
Novartis drug Afinitor® met primary endpoint of Phase III study in women with advanced breast cancer; ...
Cancer treatments: New information from fission yeast
Basilea initiates first-in-human study with its novel anti-cancer drug BAL101553
Genentech Provides Update from FDA Hearing on Avastin for Metastatic Breast Cancer
Roche provides update from FDA hearing on Avastin for metastatic breast cancer
Life Technologies Consortium to Create New Frontline Diagnostic Utilising DNA Sequencing for Cancer Patients ...
Abbott Receives FDA Approval for a New Six-Month Formulation of Lupron Depot® (leuprolide acetate for ...
Genentech, Curis Pass Clinical Trial With Skin Cancer Drug, Look Ahead to FDA
Pivotal study showed vismodegib helped shrink tumours or heal lesions in people with rare form of advanced ...
New Data in Breast and Ovarian Cancer Presented at ASCO Support Continued Development of Iniparib
ZALTRAP Significantly Improved Survival in Previously Treated Metastatic Colorectal Cancer Patients
Blood Clotting and Bowel Cancer Risk
Teva Announces Successful Results of Phase III Study of Its Long-Acting G-CSF Product in Breast Cancer ...
Phase 1b Trial of Retaspimycin HCl in Combination With Docetaxel Shows Encouraging Response Rates in ...
Alpharadin Significantly Improves Overall Survival in Phase III Trial in Patients with Prostate Cancer
Review: “DKFZ-ZMBH Alliance Forum on Aging & Cancer” in Heidelberg
Infinity Reports Results From Phase 1b Clinical Trial of IPI-926 in Pancreatic Cancer at ASCO Meeting
Roche announces data to show Avastin based regimen halved the risk of disease getting worse in women ...
New Study Showed Patients With Deadly Form of Lung Cancer Lived Longer Without Disease Worsening
Tarceva nearly doubled the time people with a genetically distinct type of lung cancer lived without ...
Roche enters collaboration with Bristol-Myers Squibb to study combination therapy with vemurafenib and ...
Teva Announces Data on Granulocyte Colony Stimulating Factor Compounds for the Prevention of Chemotherapy-Induced ...


